Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unacylated Ghrelin to Improve Functioning in PAD: The GIFT Trial Phase II

NCT04377126 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04377126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unacylated Ghrelin to Improve Functioning in PAD: The GIFT Trial Phase II
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
July 8, 2020
Completion date
January 23, 2025
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease